Network meta‐analysis of upfront fixed‐duration therapies in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Network meta‐analysis of upfront fixed‐duration therapies in chronic lymphocytic leukemia

Published:2024-07-23 Issue:10 Volume:99 Page:2041-2044
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Molica Stefano¹^ORCID,Allsup David¹²^ORCID,Giannarelli Diana³

Affiliation:

1. Department of Hematology Hull University Teaching Hospitals NHS Trust Hull UK

2. Centre for Biomedicine Hull York Medical School Hull UK

3. Biostatistics Unit Scientific Directorate Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27437

Reference22 articles.

1. Emerging bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia: one step ahead ibrutinib

2. Final analysis of the RESONATE‐2 study: up to 10 years of follow‐up of first‐line ibrutinib treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma;Burger J;HemaSphere,2024

3. Managing toxicities of Bruton tyrosine kinase inhibitors

4. Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies

5. Time-limited, chemotherapy-free treatment comes of age in chronic lymphocytic leukaemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP